Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Omkar PharmachemBOM:532167 52 OCF Yield % is 1.46 as of Jul. 29, 2026. GuruFocus rates BOM:532167 with a GF Score™ of 52/100 and a GF Value™ of ₹23.90 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 1,086 Business Services companies, Omkar Pharmachem ranks worse than 72.28% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Omkar Pharmachem OCF Yield % Related Terms
Omkar Pharmachem OCF Yield % Historical Data
* Premium members only.
The historical data trend for Omkar Pharmachem's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532167 vs CTAS, CPRT, GPN: OCF Yield % Comparison
For the Specialty Business Services subindustry, Omkar Pharmachem's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omkar Pharmachem OCF Yield % vs Business Services Industry
For the Business Services industry and Industrials sector, Omkar Pharmachem's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Omkar Pharmachem's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omkar Pharmachem (BOM:532167) has a OCF Yield % of 1.46 as of Jul. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Omkar Pharmachem and its competitors. Over the past decade, Omkar Pharmachem's OCF Yield % has ranged from 1.46 to 1.46. According to the industry distribution chart, Omkar Pharmachem ranks #785 out of 1086 companies in the Business Services industry, placing it in the top 72.3%.
Is Omkar Pharmachem's OCF Yield % too high?
Omkar Pharmachem's current OCF Yield % is 1.46. Over the past 10 years, this metric has ranged from a low of 1.46 to a high of 1.46. The Business Services industry median OCF Yield % is 7.24. Omkar Pharmachem's value of 1.46 is 79.8% below this industry median. Based on the distribution chart, Omkar Pharmachem ranks #785 out of 1086 companies in the Business Services industry, which is below the industry midpoint. Overall, Omkar Pharmachem has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Omkar Pharmachem's OCF Yield % compare to CTAS and CPRT?
According to the Business Services industry distribution chart, Omkar Pharmachem ranks #785 out of 1086 companies for OCF Yield %. This places Omkar Pharmachem in the lower half of its industry. The industry median OCF Yield % is 7.24. Omkar Pharmachem's value of 1.46 is 79.8% below this benchmark. Historically, Omkar Pharmachem's own OCF Yield % has ranged from 1.46 to 1.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Business Services company?
The median OCF Yield % among Business Services companies is 7.24, based on 1,086 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omkar Pharmachem's current OCF Yield % of 1.46 is 79.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Omkar Pharmachem and its competitors. For the Business Services industry, the median OCF Yield % is 7.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omkar Pharmachem's current OCF Yield % is 1.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omkar Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Omkar Pharmachem (BOM:532167) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹23.90, compared to a current price of ₹16.30 — trading 31.8% below its estimated fair value. The current OCF Yield % is 1.46 and 79.8% below the Business Services industry median of 7.24. Omkar Pharmachem's overall GF Score™ is 52/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Omkar Pharmachem (BOM:532167), the current OCF Yield % is 1.46 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omkar Pharmachem (BOM:532167) Overvalued in 2026?
Based on GuruFocus' analysis, Omkar Pharmachem stock appears to be undervalued.
The current stock price of ₹16.30 is trading 31.8% below its estimated GF Value™ of ₹23.90.
GuruFocus considers Omkar Pharmachem to be Significantly Undervalued.
Key valuation signals for BOM:532167:
OCF Yield %: 1.46
GF Value™: ₹23.90 vs. price of ₹16.30 (31.8% below fair value)
Industry Position: 79.8% below the Business Services median (#785 of 1086)
No single metric tells the full story. See the BOM:532167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532167 has been successfully added to your 
